Craig Thompson, chair of the Cancer Center Memorial Sloan-Kettering in New York yesterday, was hit with a second lawsuit alleging that it made a bad business deal to exploit research on the metabolism of cancer cells.
The University of Pennsylvania has filed a lawsuit in US federal court in Manhattan accusing Thompson-old Penn employee failed to share intellectual property of its findings with the university as it was required to do so. Instead, the Penn claims, Thompson released the results of its group of cancer variant cellular enzymes in Nature and Cancer Cell while helping a private company seeking patents on discoveries. This repeats certain costs of a complaint in December, when Thompson was sued by Leonard and Madlyn Abramson Family Institute, part of a research university on the transaction related cancer Thompson previously directed. He was accused of sharing intellectual property with bad company he helped launch, Agios Pharmaceuticals of Cambridge, Massachusetts. Penn and the Abramson center Agios both included as a defendant.
In her complaint, Penn alleges that Thompson violated the rules on the university's patents and "breached its fiduciary duty to the university" by "failing to disclose to the research and discoveries academics. "instead, she claims, he shared the results with Agios, which filed patents, and disclosed his work in international journals," at the expense of the university. "
Agios, with $ in outside support 150 million, hopes to develop new therapies based on this research
in response, Thompson said. "I believe that the allegations in the complaint Penn is unfounded, both in fact and law. I am very disappointed that Penn chose to file its lawsuit without making any effort to talk with me or know the real facts before filing a suit that night unjustly my reputation. " A spokesman said that Agios Agios "believes he has done nothing wrong ... and fully expects to be justified."
0 Komentar